Article info
PDFExtended reports
Observational study on efficacy, safety, and drug survival of anakinra in rheumatoid arthritis patients in clinical practice
- Correspondence to:
Dr A A den Broeder
Department of Rheumatology, UMCN st Radboud, PO box 9101, 6500 HB Nijmegen, Netherlands; alfons{at}denbroeder.org
Citation
Observational study on efficacy, safety, and drug survival of anakinra in rheumatoid arthritis patients in clinical practice
Publication history
- Accepted October 26, 2005
- First published November 3, 2005.
Online issue publication
January 10, 2022
Article Versions
- Previous version (9 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2006 by Annals of the Rheumatic Diseases